Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by Teddy3on Aug 31, 2021 10:16am
122 Views
Post# 33787405

RE:RE:Fair value share price - $9.64

RE:RE:Fair value share price - $9.64The smart suits wont touch this with a 10 foot pole. They know better. SocitiaBank agrees, you have to call in to buy SZLS on Scotia iTrade now as they will advise this is a known "pump and dump" company. Good on them for looking out for their customers.

Volume still awful as the only people buying are small speculatory investors. This is dead until volume returns. This likely will not happen until next finacials many months away. Plus, they will have to show covid revenue has returned and decent Aristotle sales which is anyones guess.

Not saying impossible, but the szls team usually preforms much worse than expectations. A pump may start soon but make sure you all sell before the crushing results and reality this next time. SZLS is like the annoying girl that gets dumped on a regular basis.
<< Previous
Bullboard Posts
Next >>